ATP6V0A2 and cancer: Due to RTF function, which regulates pH in tumor milieu, it has been considered as an ideal target for cancer immunotherapy, and an anti-RTF monoclonal antibody has been capable of inducing apoptosis in an ovarian carcinoma cell line13.